Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -5927.00x is in line with its 1-year average of -5418.00x, near the low end of its 1-year range (-5927.00x–-4909.00x).
As of the fiscal period ended Wednesday, March 31, 2021.
Reported quarterly interest coverage; no daily interpolation.
Limited quarterly history available
Interest Coverage needs at least three reported quarters before a meaningful chart is shown.
INTEREST COVERAGE RATIO
-5927.00x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.64x
median of 464 covered companies
CURRENT VS SECTOR MEDIAN
-104895.57%
vs the sector median at left
Aura Biosciences, Inc.
Market Cap
$636.13M
Interest Coverage Ratio
-5927.00x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$633.99M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$605.73M
Interest Coverage Ratio
-133.54x
TTM Avg
0.30x
3Y Avg
1.45x
5Y Avg
7.08x
Market Cap
$670.10M
Interest Coverage Ratio
35.83x
TTM Avg
47.17x
3Y Avg
33.36x
5Y Avg
33.36x
Market Cap
$600.01M
Interest Coverage Ratio
3.63x
TTM Avg
3.22x
3Y Avg
13.13x
5Y Avg
10.34x
Market Cap
$672.52M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$593.40M
Interest Coverage Ratio
-1214.61x
TTM Avg
176.24x
3Y Avg
176.24x
5Y Avg
176.24x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aura Biosciences, Inc. (AURA) | $636.13M | -5927.00x | N/A | N/A | N/A |
| Prime Medicine, Inc. (PRME)vs › | $633.99M | N/A | N/A | N/A | N/A |
| Climb Bio, Inc. (CLYM)vs › | $633.33M | N/A | N/A | N/A | N/A |
| OmniAb, Inc. (OABI)vs › | $650.93M | N/A | N/A | N/A | N/A |
| AngioDynamics, Inc. (ANGO)vs › | $605.73M | -133.54x | 0.30x | 1.45x | 7.08x |
| MiMedx Group, Inc. (MDXG)vs › | $670.10M | 35.83x | 47.17x | 33.36x | 33.36x |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $600.01M | 3.63x | 3.22x | 13.13x | 10.34x |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $672.52M | N/A | N/A | N/A | N/A |
| Fulgent Genetics, Inc. (FLGT)vs › | $593.40M | -1214.61x | 176.24x | 176.24x | 176.24x |
| Annexon, Inc. (ANNX)vs › | $679.13M | N/A | N/A | N/A | N/A |
Interest Coverage
-5927.0x
Debt/Equity
0.05
Current Ratio
16.82
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2021-03-31 | -5927.00x |
| 2020-12-31 | -4909.00x |
